非维生素K拮抗剂口服抗凝药相关脑出血的神经影像与临床结局
该系统综述与个体患者数据Meta分析纳入7项队列研究,比较非维生素K拮抗剂口服抗凝药相关脑出血(NOAC-ICH)与维生素K拮抗剂相关脑出血(VKA-ICH)的临床与影像结局。NOAC-ICH组30天死亡率与VKA-ICH组相似,但入院NIHSS评分更低、严重卒中比例更低、基线血肿体积更小。
要点
- NOAC-ICH与VKA-ICH的30天死亡率相似(24.3% vs 26.5%;HR=0.94,95%CI=0.67-1.31)。
- 校正混杂因素后,NOAC-ICH与更低的入院NIHSS评分相关(回归系数=-2.83,95%CI=-5.28至-0.38)。
- NOAC-ICH与更低的严重卒中(NIHSS>10分)几率(OR=0.50,95%CI=0.30-0.84)及更小的基线血肿体积相关。
核心结论
- NOAC-ICH与VKA-ICH患者出院时、1个月或3个月的功能结局相当,但NOAC-ICH患者基线血肿体积更小、急性卒中综合征更轻。
研究设计与样本
- 系统综述与个体患者数据Meta分析,纳入7项比较NOAC-ICH与VKA-ICH临床和影像结局的队列研究,共219例NOAC-ICH和831例VKA-ICH患者(平均年龄77岁,52.5%为女性)。
主要发现
- NOAC-ICH组与VKA-ICH组的30天死亡率相似(24.3% vs 26.5%;HR=0.94,95%CI=0.67-1.31)。
- 多变量分析中,NOAC-ICH与更低的入院NIHSS评分相关(线性回归系数=-2.83,95%CI=-5.28至-0.38)。
- NOAC-ICH与更低的入院严重卒中(NIHSS>10分)几率相关(OR=0.50,95%CI=0.30-0.84)。
- NOAC-ICH与更小的基线血肿体积相关(线性回归系数=-0.24,95%CI=-0.47至-0.16)。
- 两组在基线血肿体积<30cm³几率(OR=1.14,95%CI=0.81-1.62)、血肿扩大(OR=0.97,95%CI=0.63-1.48)、院内死亡率(OR=0.73,95%CI=0.49-1.11)、出院时功能状态(common OR=0.78,95%CI=0.57-1.07)及3个月功能状态(common OR=1.03,95%CI=0.75-1.43)方面无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Whether intracerebral hemorrhage (ICH) associated with non-vitamin K antagonist oral anticoagulants (NOAC-ICH) has a better outcome compared to ICH associated with vitamin K antagonists (VKA-ICH) is uncertain. METHODS: We performed a systematic review and individual patient data meta-analysis of cohort studies comparing clinical and radiological outcomes between NOAC-ICH and VKA-ICH patients. The primary outcome measure was 30-day all-cause mortality. All outcomes were assessed in multivariate regression analyses adjusted for age, sex, ICH location, and intraventricular hemorrhage extension. RESULTS: We included 7 eligible studies comprising 219 NOAC-ICH and 831 VKA-ICH patients (mean age = 77 years, 52.5% females). The 30-day mortality was similar between NOAC-ICH and VKA-ICH (24.3% vs 26.5%; hazard ratio = 0.94, 95% confidence interval [CI] = 0.67-1.31). However, in multivariate analyses adjusting for potential confounders, NOAC-ICH was associated with lower admission National Institutes of Health Stroke Scale (NIHSS) score (linear regression coefficient = -2.83, 95% CI = -5.28 to -0.38), lower likelihood of severe stroke (NIHSS > 10 points) on admission (odds ratio [OR] = 0.50, 95% CI = 0.30-0.84), and smaller baseline hematoma volume (linear regression coefficient = -0.24, 95% CI = -0.47 to -0.16). The two groups did not differ in the likelihood of baseline hematoma volume < 30cm3 (OR = 1.14, 95% CI = 0.81-1.62), hematoma expansion (OR = 0.97, 95% CI = 0.63-1.48), in-hospital mortality (OR = 0.73, 95% CI = 0.49-1.11), functional status at discharge (common OR = 0.78, 95% CI = 0.57-1.07), or functional status at 3 months (common OR = 1.03, 95% CI = 0.75-1.43). INTERPRETATION: Although functional outcome at discharge, 1 month, or 3 months was comparable after NOAC-ICH and VKA-ICH, patients with NOAC-ICH had smaller baseline hematoma volumes and less severe acute stroke syndromes. Ann Neurol 2018;84:702-712.
引用
- Tsivgoulis G, Wilson D, Katsanos AH, et al. Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage. Ann Neurol. 2018. PMID: 30255970. doi:10.1002/ana.25342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。